N/A
Completed N=20
Effect of Hearing Aid Labeling on Speech Understanding Measures
Source: ClinicalTrials.gov NCT05274178 ↗Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Jul 2023
Primary outcomePrimary: Quick Speech in Noise Test (QuickSIN) — 6.2; 9.6; 5.2; 10 decibels (dB) — p=>.05
Summary
New and experienced hearing aid users will be fit with two hearing devices. One will be labeled as an OTC (Over-The-Counter) device, the other will be labeled as a Prescriptive (i.e. professionally fit) device. Both devices will be generically programmed for a mild to moderate hearing loss. An objective speech in noise test will be completed with both devices.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Quick Speech in Noise Test (QuickSIN) |
6.2; 9.6; 5.2; 10 | >.05 |
Eligibility Criteria
Inclusion Criteria
- Adults age 18 or older with bilateral mild to moderate hearing loss
- Experienced users must have at least 6 months Hearing Aid experience
- New users must have no prior hearing aid experience, defined as never owning their own devices
Exclusion Criteria
- Self-reported ear related pathology (otorrhea w/in 90 days, dizziness, sudden hearing loss or worsening of hearing w/in 90 days, otalgia)
- Visible deformity of the ear
- Chronic, severe tinnitus
- Unilateral hearing loss
- Cognitive impairment
Data sourced from ClinicalTrials.gov (NCT05274178). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.